Australia
Australia Kidney Function Tests Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Australia · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
China at $191.5 Mn.
India at 9.3% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$27.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $28.5 Mn | — | — |
| 2025 (base) | $30.6 Mn | +$2.1 Mn | — |
| 2026 (forecast) | $32.8 Mn | +$2.3 Mn | +7.4% |
| 2027 (forecast) | $35.3 Mn | +$2.4 Mn | +15.3% |
| 2028 (forecast) | $37.9 Mn | +$2.6 Mn | +23.9% |
| 2029 (forecast) | $40.7 Mn | +$2.8 Mn | +33.1% |
| 2030 (forecast) | $43.7 Mn | +$3.0 Mn | +42.9% |
| 2031 (forecast) | $46.9 Mn | +$3.2 Mn | +53.5% |
| 2032 (forecast) | $50.4 Mn | +$3.5 Mn | +64.8% |
| 2033 (forecast) | $54.1 Mn | +$3.7 Mn | +77% |
| 2034 (forecast) | $58.1 Mn | +$4.0 Mn | +90.1% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$1.02 Bn
China
$191.5 Mn
Canada
$166.3 Mn
Japan
$161.5 Mn
Germany
$69.8 Mn
France
$64.8 Mn
Brazil
$59.1 Mn
UK
$50.4 Mn
Italy
$48.5 Mn
Spain
$40.8 Mn
Saudi Arabia
$40.8 Mn
Ecuador
$39.8 Mn
India
$37.4 Mn
Mexico
$30.3 Mn
Australia (this report)
$30.6 Mn
Russia
$20.3 Mn
New Zealand
$19.6 Mn
South Africa
$12.9 Mn
UAE
$10.6 Mn
Egypt
$6.8 Mn
Philippines
$4.6 Mn
Malaysia
$3.9 Mn
Thailand
$3.2 Mn
Hong Kong
$3.1 Mn
Singapore
$3.1 Mn
Kenya
$1.4 Mn
Kidney function tests measure creatinine, protein in urine and other markers to find and track kidney disease.
Key segments of the kidney Function Tests market include test (Serum Creatinine, eGFR and Urine Albumin) and setting (Labs, Point of Care and Home).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the kidney Function Tests market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the kidney Function Tests market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the kidney Function Tests market.
The kidney Function Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how kidney Function Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.
What doctors and scientists are doing in Kidney Function Tests right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Australia · 2 shared keywords
Australia · 2 shared keywords
Australia · 1 shared keyword
Australia · 1 shared keyword
Australia · 1 shared keyword
Australia · 1 shared keyword
Digital Health · Australia
Healthcare Services · Australia
Healthcare Services · Australia
Pharmaceuticals · Australia
Healthcare Services · Australia
Healthcare Services · Australia